Safety Considerations and Who May Benefit Whilst GLP-1 receptor agonists are generally well-tolerated, understanding their adverse effect profile is essential for appropriate patient selection and monitoring
Asia-Pacific is the fastest-growing regional GLP-1 drug market at 22.6% CAGR , driven by rapidly rising obesity prevalence China now reports 18.6% adult obesity prevalence up from 7.1% in 2000 combined with expanding private health insurance and regulatory approvals
For example, GLP-1R in adipocytes can directly regulate apoptosis and preadipocyte proliferation by activating the adenylate cyclase/cyclic adenosine monophosphate (AC/cAMP) signaling pathway and various cell signaling cascades, including extracellular signal-regulated kinase (ERK), protein kinase C (PKC), and protein kinase B (AKT) [41,46]
MC4R and MC3R activation in areas such as the paraventricular nucleus, nucleus accumbens, and spinal pathways mediates sexual arousal and erectile function through both central and peripheral mechanisms